Chronic Coronary Syndrome
Conditions
Interventions
Treatment group:TEAS Zusanli/Neiguan+Western medicine
Control group:Western medicine
Sponsors
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the 2019 ESC Guidelines for the diagnosis and management chronic coronary syndromes; (2) Stable angina pectoris; (3) The classification criteria for angina pectoris are based on the severity classification of angina pectoris by the Canadian Cardiovascular Society, which is divided into levels I, II, and III; (4) Age ranging from 30 to 80 years old, regardless of gender; (5) Sign an informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: (1) Poor control of blood pressure and blood sugar; (2) Severe cardiovascular diseases such as severe cardiopulmonary insufficiency, severe arrhythmia, severe arterial stenosis, dissection, etc; (3) Patients with severe cerebrovascular diseases, liver, kidney or blood system diseases, or malignant tumors; (4) Individuals with bleeding tendencies or allergic constitution; (5) Patients with pacemakers installed; (6) Pregnant or lactating women, or those with fertility requirements in the past six months; (7) Those who have merged mental illnesses or are unwilling to cooperate; (8) Individuals who have participated or are currently participating in other clinical trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6-MWT;SAQ; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;Electrocardiogram;hs-CRP;Frequency of angina attacks;Usage of Nitroglycerin;Heart rate variability;Blood routine;Urinalysis;Liver function;Renal function;PT APTT TT FIB; | — |
Countries
China
Contacts
Public ContactHanxingjun
The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Outcome results
None listed